Citigroup
ZBH icon

Citigroup’s Zimmer Biomet ZBH Stock Holding History

Citigroup’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,751
Closed -$262K – 7555
2020
Q4 		$262K Sell
1,751
-6,077
-78% -$858K ﹤0.01% 4778
2020
Q3 		$1.03M Buy
7,828
+4,738
+153% +$619K ﹤0.01% 3245
2020
Q2 		$358K Sell
3,090
-22,351
-88% -$2.58M ﹤0.01% 4556
2020
Q1 		$2.5M Sell
25,441
-9,579
-27% -$1.26M ﹤0.01% 2269
2019
Q4 		$5.09M Buy
35,020
+17,510
+100% +$2.42M ﹤0.01% 2016
2019
Q3 		$2.33M Buy
17,510
+8,446
+93% +$1.09M ﹤0.01% 2687
2019
Q2 		$1.04M Sell
9,064
-22,248
-71% -$2.61M ﹤0.01% 3580
2019
Q1 		$3.88M Buy
31,312
+2,987
+11% +$339K ﹤0.01% 2009
2018
Q4 		$2.85M Buy
28,325
+24,514
+643% +$2.76M ﹤0.01% 2332
2018
Q3 		$486K Sell
3,811
-13,184
-78% -$1.57M ﹤0.01% 4314
2018
Q2 		$1.84M Sell
16,995
-15,347
-47% -$1.67M ﹤0.01% 2747
2018
Q1 		$3.42M Sell
32,342
-10,197
-24% -$1.18M ﹤0.01% 2124
2017
Q4 		$4.98M Buy
42,539
+33,578
+375% +$3.8M ﹤0.01% 1838
2017
Q3 		$1.02M Buy
8,961
+206
+2% +$23.8K ﹤0.01% 3360
2017
Q2 		$1.09M Buy
8,755
+103
+1% +$12.2K ﹤0.01% 3217
2017
Q1 		$1.03M Sell
8,652
-13,287
-61% -$1.51M ﹤0.01% 3179
2016
Q4 		$2.2M Sell
21,939
-6,901
-24% -$740K ﹤0.01% 2829
2016
Q3 		$3.64M Buy
+28,840
New +$3.56M ﹤0.01% 1966
2016
Q2 		– Sell
-7,519
Closed -$778K – 7483
2016
Q1 		$778K Buy
+7,519
New +$727K ﹤0.01% 3634
2015
Q3 		– Sell
-25,132
Closed -$2.67M – 7757
2015
Q2 		$2.67M Buy
+25,132
New +$2.78M ﹤0.01% 2276
2014
Q1 		– Sell
-8,240
Closed -$746K – 7233
2013
Q4 		$746K Sell
8,240
-33,887
-80% -$2.93M ﹤0.01% 3458
2013
Q3 		$3.36M Sell
42,127
-19,776
-32% -$1.56M ﹤0.01% 2092
2013
Q2 		$4.5M Buy
+61,903
New +$4.63M ﹤0.01% 1730

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's ZBH Position: Q1 2026 in Review

Citigroup reduced its Zimmer Biomet (ZBH) stake by 3.2% in Q1 2026, selling an estimated $582K and leaving 194,382 shares worth $17.6M. The position accounts for 0.01% of the portfolio, ranked #1141.

Citigroup first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $76.6M in Q1 2021. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Citigroup held 194,382 shares of Zimmer Biomet worth $17.6M as of Q1 2026.
  • Citigroup sold 6,346 Zimmer Biomet shares in Q1 2026, an estimated $582K.
  • Zimmer Biomet made up 0.01% of Citigroup's portfolio in Q1 2026, its #1141 holding.
  • Citigroup first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Zimmer Biomet position peaked at $76.6M in Q1 2021.
  • 913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.